What does FRx stand for?
Apr 12, 2022 · Forest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York. Read More Headlines
Why is forest road (FRx) stock going up Wednesday?
Dec 08, 2021 · Check if FRX Stock has a Buy or Sell Evaluation. FRX Stock Price (NYSE), Forecast, Predictions, Stock Analysis and Forest Road Acquisition Corp. News.
What are analysts'target prices for FRx stock?
Real time Forest Road Acquisition Corp. (FRX) stock price quote, stock graph, news & analysis.
How do I buy FRx shares?
Mar 29, 2022 · Fennec Pharmaceuticals' stock was trading at C$9.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, FRX stock has decreased by 19.1% and is now trading at C$7.30. View which stocks have been most impacted by COVID-19.
What is FRX in investing?
Industry Leaders in Strategy, Operations, and Investing. Forest Road Acquisition Corp. (NYSE: FRX) is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Is Forest Road stock a good buy?
Forest Road Acquisition has received a consensus rating of Buy.
Who owns FRX stock?
Forest Road Company, LLCForest Road Company, LLC is currently the largest shareholder, with 20% of shares outstanding. For context, the second largest shareholder holds about 5.7% of the shares outstanding, followed by an ownership of 4.5% by the third-largest shareholder.May 25, 2021
Is FRX shorted?
Short Shares Availability This table shows the number of shares of US:FRX available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
Will FRX stock become BODY?
As announced previously, upon the effectiveness of the business combination, Forest Road will change its name to “The Beachbody Company, Inc.” and its common stock and warrants are expected to be traded on the New York Stock Exchange under the new symbols “BODY” and “BODY WS”, respectively.Jun 23, 2021
What happens to my FRX shares after merger?
When the deal closes, shares of FRX stock will continue to trade on the New York Stock Exchange. However, the ticker won't be the same. It will be switched over to the BODY ticker for the new company. The Forest Road SPAC merger values the combined company at $2.9 billion.Feb 10, 2021
Who is FRX merging with?
Beachbody Company Group(NYSE:FRX) ("Forest Road") today announced that its stockholders have voted to approve the proposed three-way business combination (the "Business Combination") with The Beachbody Company Group, LLC ("Beachbody") and Myx Fitness Holdings, LLC ("Myx") at its special meeting of stockholders (the "Special Meeting") held ...Jun 24, 2021
Is Forest Road Acquisition a buy right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Forest Road Acquisition in the last year. There are currently 1 h...
What price target have analysts set for FRX?
2 brokerages have issued 1 year price targets for Forest Road Acquisition's shares. Their forecasts range from $11.00 to $14.50. On average, they e...
Who are Forest Road Acquisition's key executives?
Forest Road Acquisition's management team includes the following people: Mr. Zachary Tarica , Chairperson of the Board & Chief Investment Officer...
Who are some of Forest Road Acquisition's key competitors?
Some companies that are related to Forest Road Acquisition include Johnson & Johnson (JNJ) , Pfizer (PFE) , AbbVie (ABBV) , Eli Lilly and (LLY)...
What other stocks do shareholders of Forest Road Acquisition own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Forest Road Acquisition investors own include Boeing (BA)...
What is Forest Road Acquisition's stock symbol?
Forest Road Acquisition trades on the New York Stock Exchange (NYSE) under the ticker symbol "FRX."
How much money does Forest Road Acquisition make?
Forest Road Acquisition has a market capitalization of $0.00.
What is Forest Road Acquisition's official website?
The official website for Forest Road Acquisition is www.frx.com .
Where are Forest Road Acquisition's headquarters?
Forest Road Acquisition is headquartered at 909 3rd Ave, NEW YORK, NY 10022-4731, United States .
Is Fennec Pharmaceuticals a buy right now?
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fennec Pharmaceuticals in the last year. There are currently 1 ho...
How has Fennec Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?
Fennec Pharmaceuticals' stock was trading at C$9.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World...
When is Fennec Pharmaceuticals' next earnings date?
Fennec Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, May 12th 2022. View our earnings forecast for...
What price target have analysts set for FRX?
4 brokers have issued twelve-month price objectives for Fennec Pharmaceuticals' shares. Their forecasts range from C$10.00 to C$10.00. On average,...
Who are Fennec Pharmaceuticals' key executives?
Fennec Pharmaceuticals' management team includes the following people: Mr. Rostislav Raykov , CEO & Director (Age 45, Pay $430k) Mr. Robert C. A...
Who are some of Fennec Pharmaceuticals' key competitors?
Some companies that are related to Fennec Pharmaceuticals include Oxford Biomedica (OXB) , PureTech Health (PRTC) , Ergomed (ERGO) , Silence Th...
What other stocks do shareholders of Fennec Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Fennec Pharmaceuticals investors own include Encanto Potas...
What is Fennec Pharmaceuticals' stock symbol?
Fennec Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "FRX."
How do I buy shares of Fennec Pharmaceuticals?
Shares of FRX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian...
Is Fennec Pharmaceuticals a buy right now?
What stocks does MarketBeat like better than Fennec Pharmaceuticals?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fennec Pharmaceuticals in the last twelve months. There are currently 2 buy ratings for the stock.
When is Fennec Pharmaceuticals' next earnings date?
Wall Street analysts have given Fennec Pharmaceuticals a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Fennec Pharmaceuticals wasn't one of them.
How has Fennec Pharmaceuticals' stock been impacted by COVID-19?
Fennec Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.#N#View our earnings forecast for Fennec Pharmaceuticals.
Who are some of Fennec Pharmaceuticals' key competitors?
Fennec Pharmaceuticals' stock was trading at C$9.02 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, FRX shares have increased by 13.7% and is now trading at C$10.26.#N#View which stocks have been most impacted by COVID-19.
What other stocks do shareholders of Fennec Pharmaceuticals own?
Some companies that are related to Fennec Pharmaceuticals include PureTech Health (PRTC), Ergomed (ERGO), Biotest Aktiengesellschaft (BIO), Brooklyn ImmunoTherapeutics (BTX), Inventiva (IVA), Silence Therapeutics (SLN), Theratechnologies (TH), Pfenex (PFNX), BELLUS Health (BLU), Nuvo Pharmaceuticals Inc.
What is Fennec Pharmaceuticals' stock symbol?
Based on aggregate information from My MarketBeat watchlists, some companies that other Fennec Pharmaceuticals investors own include Encanto Potash (EPO), Acadian Timber (ADN), (AD), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB), Air Canada (AC) and Barrick Gold (ABX)..
Beachbody versus Peloton
Fennec Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "FRX."
Beachbody versus Peloton valuation
Beachbody and Peloton’s business models are similar. Both of the companies offer subscription-based services where you can stream online workout videos and live videos from anywhere. Some of the workouts on both of the apps require equipment, while others don't.
Outlook for the home fitness market
Currently, Peloton trades at an EV-to-NTM sales multiple of 6.8x, while its EV-to-NTM EBITDA multiple is a mind-boggling 106.8x. The ones who are very optimistic about the at-home fitness trend try to justify this valuation by saying that the company is in a very high growth phase, which is true.
FRX's stock forecast
The outlook for the home fitness market was strong anyway but the COVID-19 pandemic has accelerated the subscription-based at-home fitness business. The trend is also expected to see strong growth. The online fitness market is expected to grow from $6 billion in 2019 to $59 billion by 2027 at a CAGR of 33 percent.
The Beachbody-FRX merger date
The current FRX SPAC stock offers exposure to Openfit and Myx Fitness, which have bright outlooks as well. The three businesses complement each others’ offerings. The combination offers holistic at-home fitness and nutrition solutions.
Beachbody stock is expected to go up after merger
Voting on the proposed deal is expected to take place on Jun. 24 at 10:00 a.m. ET. The transaction will be completed as soon as it's approved. Beachbody stock is set to trade on the NYSE under a new ticker symbol, “BODY”.
What happens to FRX SPAC stock after the merger?
Beachbody stock has the potential to climb higher, thanks to the fitness company’s strong growth prospects. The global online fitness market, valued at $6 billion in 2019, is set to reach $59.2 billion in value by 2027, according to Allied Market Research estimates. The subscription-based at-home fitness market has grown amid the COVID-19 pandemic.